Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

KSP inhibition with ARRY-520 shows antitumor activity in animal models of solid tumors

April 27, 2007

Preclinical profile of the kinase inhibitor R-1530 reported by Roche

April 27, 2007

PCK-3145 shows evidence of clinical activity in metastatic prostate cancer patients

April 26, 2007

Dosing completed in phase I metastatic melanoma study of Provecta

April 26, 2007

Exelixis cleared to resume clinical testing of XL-999

April 26, 2007

Agensys discover AGS-16 as a novel target for the treatment of kidney cancer

April 26, 2007

Introgen initiates efficacy analyses of Advexin phase III study

April 26, 2007

Promising preclinical profile of STI-1698, a topoisomerase I inhibitor developed at Sigma-Tau

April 26, 2007

Novel camptothecin conjugate with promising efficacy and pharmacokinetic profile

April 26, 2007

FdCyd and THU studied for treatment of solid tumors

April 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...